ClinicalTrials.Veeva

Menu

Periodontal Health Status in Patients with Systemic Sclerosis

U

University of Belgrade

Status

Enrolling

Conditions

Periodontitis
Systemic Sclerosis

Treatments

Diagnostic Test: Activity of antioxidants in unstimulated saliva (GPX, SOD, UA)
Procedure: periodontal examination's, determination of salivary antioxidants and cytokine levels (VEGF, TGF-β, Il-17) in gingival crevicular fluid, Non-surgical therapy of periodontitis
Diagnostic Test: Total cytokine levels (VEGF, TGF-β, Il-17) in gingival crevicular fluid
Procedure: Periodontal treatment

Study type

Interventional

Funder types

Other

Identifiers

NCT05215431
Unique Protocol ID: UBelgrade7

Details and patient eligibility

About

The aim of the research will be to evaluate the effects of NSPT on clinical periodontal parameters, level of antioxidants in unstimulated saliva and the levels of biomarkers (VEGF, TGF-β, IL-17) in the GCF in SSc patients in comparison with systemically healthy controls. Twenty systemic sclerosis patients with periodontitis (SS group) and twenty systemically healthy periodontitis patients (P group) will be enrolled in the present study. The results may indicate higher periodontal destruction and antioxidant perturbations in unstimulated saliva of systemic sclerosis patients with periodontitis compared to systemically healthy periodontitis patients.

Enrollment

60 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • established diagnoses of systemic sclerosis and periodontitis (study group),
  • age ≥ 18
  • presence of minimum 12 teeth

Exclusion criteria

  • concurrent inflammatory mediated rheumatic diseases
  • pregnancy or lactation
  • active cigarette smokers
  • a history of periodontal, antibiotics or non-steroidal drug therapy in the past 6 months.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

systemic sclerosis group
Experimental group
Description:
Patients with established diagnoses of systemic sclerosis and periodontitis
Treatment:
Procedure: Periodontal treatment
Diagnostic Test: Total cytokine levels (VEGF, TGF-β, Il-17) in gingival crevicular fluid
Procedure: periodontal examination's, determination of salivary antioxidants and cytokine levels (VEGF, TGF-β, Il-17) in gingival crevicular fluid, Non-surgical therapy of periodontitis
Diagnostic Test: Activity of antioxidants in unstimulated saliva (GPX, SOD, UA)
periodontitis group
Experimental group
Description:
Systemically healthy periodontitis patients
Treatment:
Procedure: Periodontal treatment
Diagnostic Test: Total cytokine levels (VEGF, TGF-β, Il-17) in gingival crevicular fluid
Procedure: periodontal examination's, determination of salivary antioxidants and cytokine levels (VEGF, TGF-β, Il-17) in gingival crevicular fluid, Non-surgical therapy of periodontitis
Diagnostic Test: Activity of antioxidants in unstimulated saliva (GPX, SOD, UA)

Trial contacts and locations

1

Loading...

Central trial contact

Natasa Nikolic Jakoba, DDS, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems